NewsRoom Articles - Page 766 of 1389

TuesdayJun 04, 2019 2:20 pm

Tiziana Life Sciences (TLSA) Starts Presentation at 9th Annual LD Micro Invitational

Tiziana Life Sciences (NASDAQ: TLSA) is a clinical-stage company developing targeted therapeutics to transform treatment of liver diseases, inflammatory diseases, and cancer. Tiziana’s two lead drug candidates, Foralumab and Milciclib, uniquely target the root cause of diseases with large unmet needs in multibillion-dollar markets. Through previous Phase II trials, both drug candidates have been de-risked by demonstration of both safety and efficacy in humans. Foralumab is the world’s first and only fully human anti-CD3 monoclonal antibody. This is a substantial advantage over similar antibody drugs which are sourced from mice and therefore cause unwanted immune responses in humans. For more…

TuesdayJun 04, 2019 2:20 pm

Cannabics Pharmaceuticals Inc. (CNBX) Starts Presentation at 9th Annual LD Micro Invitational

Cannabics Pharmaceuticals (OTC: CNBX) is developing a platform which leverages novel drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer. For more information, visit the company’s website at www.cannabics.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

TuesdayJun 04, 2019 2:00 pm

Adamis Pharmaceuticals (ADMP) Starts Presentation at 9th Annual LD Micro Invitational

Adamis Pharmaceuticals (NASDAQ: ADMP) is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company’s SYMJEPITM (epinephrine) Injection 0.3mg and SYMJEPITM (epinephrine) Injection 0.15mg products were approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis is developing additional products, including a naloxone injection product candidate for the treatment of opioid overdose, a sublingual tadalafil product candidate for the treatment of erectile dysfunction, and a metered dose inhaler and dry powder inhaler product candidates for the treatment of asthma and COPD.…

TuesdayJun 04, 2019 2:00 pm

Gan Plc (GMMNF) Starts Presentation at 9th Annual LD Micro Invitational

Gan Plc (OTC: GMMNF) is a developer and supplier of online gaming content and enterprise-level business to business gaming software systems as well as a provider of supporting operational services. GAN has developed the GameSTACK Internet Gaming System (or “IGS”) which it licenses to online and land-based gaming operators as a turnkey technology solution for both regulated real-money and Simulated Gaming online. The GameSTACK IGS, developed in London under a UKGC license, is certified to the highest technical standards currently required by gaming regulators. For more information, visit the company's website at www.gan.com/investors. About NetworkNewsWire NetworkNewsWire (NNW) is an information…

TuesdayJun 04, 2019 2:00 pm

Reeds Inc. (REED) Starts Presentation at 9th Annual LD Micro Invitational

Reeds (NYSE: REED) has sold over 500 million bottles of its category leading natural, handcrafted beverages. Reed’s is America’s #1 selling Ginger Beer brand. Virgil’s is America’s #1 selling independent, full line of natural craft sodas. The Reed’s Inc. portfolio is sold in over 30,000 retail locations across the natural, specialty, grocery, drug, club and mass channels nationwide. Reed’s Ginger Beers are unique to the category because of the proprietary process of hand brewing its award-winning products. The company uses the same handcrafted approach and dedication to the highest quality ingredients in its award-winning Virgil’s line of craft sodas. For…

TuesdayJun 04, 2019 2:00 pm

Freedom Holding Corp. (FRHC) Starts Presentation at 9th Annual LD Micro Invitational

Freedom Holding (OTC: FRHC) is a financial services holding company conducting retail financial brokerage, investment counseling, securities trading, investment banking and underwriting services through its subsidiaries under the name of Freedom Finance in the Commonwealth of Independent States (CIS). The company is a member of the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), the Saint-Petersburg Exchange (SPB) the Republican Stock Exchange of Tashkent (UZSE) and the Ukrainian Exchange. The company is headquartered in Almaty, Kazakhstan, with executive office locations in Russia and the United States. The company has branch offices in Kazakhstan, Russia, Kyrgyzstan, Ukraine and Cyprus. For more information,…

TuesdayJun 04, 2019 2:00 pm

Beyond Commerce Inc. (BYOC) Starts Presentation at 9th Annual LD Micro Invitational

Beyond Commerce (OTC: BYOC) operates as a holding company that focuses on “big data” companies in the global B2B Internet Marketing Analytics/Technology and Services space. The company’s focus is to develop, acquire, and deploy disruptive strategic software technology and market-changing business models through acquisition or organic growth. For more information, visit the company's website at www.beyondcommerceinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate…

TuesdayJun 04, 2019 1:40 pm

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6) Starts Presentation at 9th Annual LD Micro Invitational

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6) builds and invests in emerging technology companies with proven business models and strong teams. Victory Square’s portfolio companies are disrupting and fundamentally changing the business model in various sectors of the global economy including fintech, insurance, health, E-gaming and SaaS. The company provides deep growth and operational support to its portfolio companies and helps them scale globally. Over time these companies are enabled to achieve significant growth and profitability. For more information, visit the company’s website at http://www.victorysquare.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our…

TuesdayJun 04, 2019 1:40 pm

Medicine Man Technologies Inc. (MDCL) Starts Presentation at 9th Annual LD Micro Invitational

Medicine Man Technologies (OTC: MDCL) is a fully integrated operator in the cannabis industry, offering consulting, retail pharma-grade products, and turnkey solutions for cannabis cultivators for over a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation, and distribution operations. The company's client portfolio includes active and past clients in 18 states and seven countries. For more information, visit the company's website at www.medicinemantechnologies.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press…

TuesdayJun 04, 2019 1:40 pm

Hoth Therapeutics Inc. (HOTH) Starts Presentation at 9th Annual LD Micro Invitational

Hoth Therapeutics (NASDAQ: HOTH) is a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform for all indications in humans. The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University of Cincinnati. The BioLexa Platform combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups by preventing the formation of infectious biofilms and the resulting clogging of sweat ducts. It is the first product candidate…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Tiziana Life Sciences (TLSA) Starts Presentation at 9th Annual LD Micro Invitational

Cannabics Pharmaceuticals Inc. (CNBX) Starts Presentation at 9th Annual LD Micro Invitational

Adamis Pharmaceuticals (ADMP) Starts Presentation at 9th Annual LD Micro Invitational

Gan Plc (GMMNF) Starts Presentation at 9th Annual LD Micro Invitational

Reeds Inc. (REED) Starts Presentation at 9th Annual LD Micro Invitational

Freedom Holding Corp. (FRHC) Starts Presentation at 9th Annual LD Micro Invitational

Beyond Commerce Inc. (BYOC) Starts Presentation at 9th Annual LD Micro Invitational

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FWB: 6F6) Starts Presentation at 9th Annual LD Micro Invitational

Medicine Man Technologies Inc. (MDCL) Starts Presentation at 9th Annual LD Micro Invitational

Hoth Therapeutics Inc. (HOTH) Starts Presentation at 9th Annual LD Micro Invitational

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search